Carpen says no plans yet to discontinue use of remdesivir in COVID-19 treatment – -after WHO trial casts doubt on effectiveness

Following the World Health Organization (WHO) publication of research from a clinical trial showing that remdesivir barely reduces the mortality rate of COVID-19 patients, member of the Georgetown Public Hospital’s Task Force for COVID-19 Dr Mahendra Carpen has said that there are no immediately plans to discontinue using it to treat patients here as it seems to be reducing the amount of time those with symptoms remain hospitalised.

The article Carpen says no plans yet to discontinue use of remdesivir in COVID-19 treatment appeared first on Stabroek News.